Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Effect of Stereotaxic C2-Ceramide Injection on the Inositol Triphosphate Levels in the Hippocampus of Adult Rats
Epilepsy
(-)
019
Authors/Disclosures
No disclosure on file
Hyun J. Cho, MD (NIH) Dr. Cho has nothing to disclose.
No disclosure on file
Makram Obeid, MD (Stark Neurosciences Reseach Institute) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Mohamad A. Mikati, MD (Duke University Medical Center) No disclosure on file
Ricardo F. Allegri, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (Institute for Neurological Research (FLENI)) Dr. Allegri has nothing to disclose.
No disclosure on file
No disclosure on file
Marcelo Berthier Torres, MD (Pfizer Spain) No disclosure on file
Scott D. Newsome, DO, FÂé¶¹´«Ã½Ó³»­ (Johns Hopkins Hospital) Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.